What is German Bionic?
German Bionic is a pioneering developer and manufacturer of intelligent exoskeletons designed to enhance worker safety and productivity in industrial production. Their flagship product, the Cray X power suit, merges human intent with machine augmentation, providing substantial support for lifting movements – up to 66 lb per lift – and delivering up to ten tons of relief per shift. This technology significantly reduces the incidence of work-related injuries and illnesses. Established in 2016 and headquartered in Augsburg, Germany, the company also maintains offices in Berlin, Tokyo, and Boston, signaling a global ambition in the burgeoning field of human augmentation for industrial applications.
How much funding has German Bionic raised?
German Bionic has raised a total of $35M across 2 funding rounds:
Series A
$20M
Debt
$15M
Series A (2020): $20M, investors not publicly disclosed
Debt (2022): $15M led by European Investment Bank
Key Investors in German Bionic
European Investment Bank
Established in 1958 and headquartered in Luxembourg, European Investment Bank (EIB) is the European Union's nonprofit long-term lending and finance institution, often supporting strategic infrastructure and innovation projects across the continent.
What's next for German Bionic?
The recent major strategic investment, alongside its overall enterprise-level funding, positions German Bionic for accelerated growth and market penetration. This capital infusion is expected to fuel further research and development, enhance manufacturing capabilities, and expand its global sales and support network. The company's focus on reducing workplace injuries through advanced exoskeleton technology aligns with increasing industry-wide emphasis on occupational health and safety, suggesting a strong trajectory for future expansion and adoption of its innovative solutions.
See full German Bionic company page
